1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as CB1 receptor modulators
Compounds and pharmaceutical compositions comprising compounds of the Formula as CB1 receptor inverse agonists useful for reducing body weight in mammals, treating cognitive impairment associated with schizophrenia, and mitigating treatment emergent weight gain observed during treatment with antipsy...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | COFFEY DAVID SCOTT HU JINGDAN SCHAUS JOHN MEHNERT KEDING STACY JO KRUSHINSKI, JR. JOSEPH HERMAN TUPPER DAVID EDWARD |
| description | Compounds and pharmaceutical compositions comprising compounds of the Formula as CB1 receptor inverse agonists useful for reducing body weight in mammals, treating cognitive impairment associated with schizophrenia, and mitigating treatment emergent weight gain observed during treatment with antipsychotics. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US8168659B2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US8168659B2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US8168659B23</originalsourceid><addsrcrecordid>eNqNirEOgjAQQLs4GPUf7gO8oRAIrBCNOzqTSs_QpNw1LQ7163XgA5zeS97bq0GfoULrwkycPZb4JP5kbxbHglubs40ScozinXWMBQoTmAR9pyHSRGGVCIvYtzc_S0e1exmf6LTxoOB6ufc3pCAjpWAmYlrHx9DouqmrtivKP5Yv0HE2ZA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as CB1 receptor modulators</title><source>esp@cenet</source><creator>COFFEY DAVID SCOTT ; HU JINGDAN ; SCHAUS JOHN MEHNERT ; KEDING STACY JO ; KRUSHINSKI, JR. JOSEPH HERMAN ; TUPPER DAVID EDWARD</creator><creatorcontrib>COFFEY DAVID SCOTT ; HU JINGDAN ; SCHAUS JOHN MEHNERT ; KEDING STACY JO ; KRUSHINSKI, JR. JOSEPH HERMAN ; TUPPER DAVID EDWARD</creatorcontrib><description>Compounds and pharmaceutical compositions comprising compounds of the Formula as CB1 receptor inverse agonists useful for reducing body weight in mammals, treating cognitive impairment associated with schizophrenia, and mitigating treatment emergent weight gain observed during treatment with antipsychotics.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120501&DB=EPODOC&CC=US&NR=8168659B2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120501&DB=EPODOC&CC=US&NR=8168659B2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>COFFEY DAVID SCOTT</creatorcontrib><creatorcontrib>HU JINGDAN</creatorcontrib><creatorcontrib>SCHAUS JOHN MEHNERT</creatorcontrib><creatorcontrib>KEDING STACY JO</creatorcontrib><creatorcontrib>KRUSHINSKI, JR. JOSEPH HERMAN</creatorcontrib><creatorcontrib>TUPPER DAVID EDWARD</creatorcontrib><title>1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as CB1 receptor modulators</title><description>Compounds and pharmaceutical compositions comprising compounds of the Formula as CB1 receptor inverse agonists useful for reducing body weight in mammals, treating cognitive impairment associated with schizophrenia, and mitigating treatment emergent weight gain observed during treatment with antipsychotics.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNirEOgjAQQLs4GPUf7gO8oRAIrBCNOzqTSs_QpNw1LQ7163XgA5zeS97bq0GfoULrwkycPZb4JP5kbxbHglubs40ScozinXWMBQoTmAR9pyHSRGGVCIvYtzc_S0e1exmf6LTxoOB6ufc3pCAjpWAmYlrHx9DouqmrtivKP5Yv0HE2ZA</recordid><startdate>20120501</startdate><enddate>20120501</enddate><creator>COFFEY DAVID SCOTT</creator><creator>HU JINGDAN</creator><creator>SCHAUS JOHN MEHNERT</creator><creator>KEDING STACY JO</creator><creator>KRUSHINSKI, JR. JOSEPH HERMAN</creator><creator>TUPPER DAVID EDWARD</creator><scope>EVB</scope></search><sort><creationdate>20120501</creationdate><title>1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as CB1 receptor modulators</title><author>COFFEY DAVID SCOTT ; HU JINGDAN ; SCHAUS JOHN MEHNERT ; KEDING STACY JO ; KRUSHINSKI, JR. JOSEPH HERMAN ; TUPPER DAVID EDWARD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US8168659B23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>COFFEY DAVID SCOTT</creatorcontrib><creatorcontrib>HU JINGDAN</creatorcontrib><creatorcontrib>SCHAUS JOHN MEHNERT</creatorcontrib><creatorcontrib>KEDING STACY JO</creatorcontrib><creatorcontrib>KRUSHINSKI, JR. JOSEPH HERMAN</creatorcontrib><creatorcontrib>TUPPER DAVID EDWARD</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>COFFEY DAVID SCOTT</au><au>HU JINGDAN</au><au>SCHAUS JOHN MEHNERT</au><au>KEDING STACY JO</au><au>KRUSHINSKI, JR. JOSEPH HERMAN</au><au>TUPPER DAVID EDWARD</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as CB1 receptor modulators</title><date>2012-05-01</date><risdate>2012</risdate><abstract>Compounds and pharmaceutical compositions comprising compounds of the Formula as CB1 receptor inverse agonists useful for reducing body weight in mammals, treating cognitive impairment associated with schizophrenia, and mitigating treatment emergent weight gain observed during treatment with antipsychotics.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US8168659B2 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | 1, 5-diphenyl-3-benzylamino-1, 5-dihydropyrrolidin-2-one as CB1 receptor modulators |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T14%3A11%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=COFFEY%20DAVID%20SCOTT&rft.date=2012-05-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS8168659B2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |